EDP Sciences logo
Submit your paper
Search
Menu
All issues Parasite, 5 2 (1998) 167-173 Article references

Articles citing this article

The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).

Cited article:

Exploring the potential of coumarin-indole hybrid scaffold as promising pharmacological agents: a review

Hiyashree Sharmah, Lokman Ali Ahmed, Babita Deka, Deepsikha Bharali, Bitu Gogoi and Pooja Patowary
Discover Chemistry 2 (1) (2025)
https://doi.org/10.1007/s44371-025-00395-6

Synthetic product-based approach toward potential antileishmanial drug development

Rohit Pal, Ghanshyam Teli, Md Jawaid Akhtar and Gurubasavaraja Swamy Purawarga Matada
European Journal of Medicinal Chemistry 263 115927 (2024)
https://doi.org/10.1016/j.ejmech.2023.115927

Étude de la sélection de bactéries résistantes aux antibiotiques dans les élevages bovins ayant recours à la paromomycine contre la cryptosporidiose du veau

Romane Dubost, Clara Bourel Conroy, Frederic Lebœuf and Yves Millemann
Le Nouveau Praticien Vétérinaire élevages & santé 16 (59) 80 (2024)
https://doi.org/10.1051/npvelsa/2025030

In Vitro and Ex Vivo Synergistic Effect of Pyrvinium Pamoate Combined with Miltefosine and Paromomycin against Leishmania

Estela Melcón-Fernández, Giulio Galli, Rafael Balaña-Fouce, Nerea García-Fernández, María Martínez-Valladares, Rosa M. Reguera, Carlos García-Estrada and Yolanda Pérez-Pertejo
Tropical Medicine and Infectious Disease 9 (2) 30 (2024)
https://doi.org/10.3390/tropicalmed9020030

Why do few drug delivery systems to combat neglected tropical diseases reach the market? An analysis from the technology’s stages

Jabson Herber Profiro de Oliveira, Igor Eduardo Silva Arruda, José Izak Ribeiro de Araújo, Luise Lopes Chaves, Mônica Felts de La Rocca Soares and José Lamartine Soares-Sobrinho
Expert Opinion on Therapeutic Patents 32 (1) 89 (2022)
https://doi.org/10.1080/13543776.2021.1970746

Conventional treatments and non-PEGylated liposome encapsulated doxorubicin for visceral leishmaniasis

Soumya Ranjan Satapathy and Rudra Narayan Sahoo
Asian Pacific Journal of Tropical Medicine 15 (7) 293 (2022)
https://doi.org/10.4103/1995-7645.348156

Experimental Selection of Paromomycin Resistance in Leishmania donovani Amastigotes Induces Variable Genomic Polymorphisms

Sarah Hendrickx, João Luís Reis-Cunha, Sarah Forrester, Daniel C. Jeffares and Guy Caljon
Microorganisms 9 (8) 1546 (2021)
https://doi.org/10.3390/microorganisms9081546

Antileishmanial Drug Discovery and Development: Time to Reset the Model?

Ana Isabel Olías-Molero, Concepción de la Fuente, Montserrat Cuquerella, Juan J. Torrado and José M. Alunda
Microorganisms 9 (12) 2500 (2021)
https://doi.org/10.3390/microorganisms9122500

Targeting the Trypanothione Reductase of Tissue-Residing Leishmania in Hosts’ Reticuloendothelial System: A Flexible Water-Soluble Ferrocenylquinoline-Based Preclinical Drug Candidate

Debarati Mukherjee, Md Yousuf, Somaditya Dey, et al.
Journal of Medicinal Chemistry 63 (24) 15621 (2020)
https://doi.org/10.1021/acs.jmedchem.0c00690

Coupling chemical mutagenesis to next generation sequencing for the identification of drug resistance mutations in Leishmania

Arijit Bhattacharya, Philippe Leprohon, Sophia Bigot, et al.
Nature Communications 10 (1) (2019)
https://doi.org/10.1038/s41467-019-13344-6

Validation of NAD synthase inhibitors for inhibiting the cell viability ofLeishmania donovani:In silicoandin vitroapproach

Haraprasad Mandal, Saravanan Vijayakumar, Shalini Yadav, Shubhankar Kumar Singh and Pradeep Das
Journal of Biomolecular Structure and Dynamics 37 (17) 4481 (2019)
https://doi.org/10.1080/07391102.2018.1552199

Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs

Alberto Rastrojo, Raquel García-Hernández, Paola Vargas, Esther Camacho, Laura Corvo, Hideo Imamura, Jean-Claude Dujardin, Santiago Castanys, Begoña Aguado, Francisco Gamarro and Jose M. Requena
International Journal for Parasitology: Drugs and Drug Resistance 8 (2) 246 (2018)
https://doi.org/10.1016/j.ijpddr.2018.04.002

Antitrypanosomal 8-Hydroxy-Naphthyridines Are Chelators of Divalent Transition Metals

Richard J. Wall, Sonia Moniz, Michael G. Thomas, et al.
Antimicrobial Agents and Chemotherapy 62 (8) (2018)
https://doi.org/10.1128/AAC.00235-18

Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs

Anke E. Kip, Jan H. M. Schellens, Jos H. Beijnen and Thomas P. C. Dorlo
Clinical Pharmacokinetics 57 (2) 151 (2018)
https://doi.org/10.1007/s40262-017-0570-0

Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress

Deepak Kumar Deep, Ruchi Singh, Vasundhra Bhandari, et al.
PLOS Neglected Tropical Diseases 11 (6) e0005641 (2017)
https://doi.org/10.1371/journal.pntd.0005641

Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum

Sarah Hendrickx, Magali Van den Kerkhof, Dorien Mabille, et al.
PLOS Neglected Tropical Diseases 11 (5) e0005620 (2017)
https://doi.org/10.1371/journal.pntd.0005620

Transcriptome profiling identifies genes/pathways associated with experimental resistance to paromomycin in Leishmania donovani

Aditya Verma, Vasundhra Bhandari, Deepak Kumar Deep, Shyam Sundar, Jean Claude Dujardin, Ruchi Singh and Poonam Salotra
International Journal for Parasitology: Drugs and Drug Resistance 7 (3) 370 (2017)
https://doi.org/10.1016/j.ijpddr.2017.10.004

Antileishmanial activity of novel indolyl–coumarin hybrids: Design, synthesis, biological evaluation, molecular docking study and in silico ADME prediction

Jaiprakash N. Sangshetti, Firoz A. Kalam Khan, Abhishek A. Kulkarni, Rajendra H. Patil, Amol M. Pachpinde, Kishan S. Lohar and Devanand B. Shinde
Bioorganic & Medicinal Chemistry Letters 26 (3) 829 (2016)
https://doi.org/10.1016/j.bmcl.2015.12.085

Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases

James S. McCarthy, Glenn W. Wortmann and Louis V. Kirchhoff
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 510 (2015)
https://doi.org/10.1016/B978-1-4557-4801-3.00041-2

Antileishmanial drug discovery: comprehensive review of the last 10 years

Jaiprakash N. Sangshetti, Firoz A. Kalam Khan, Abhishek A. Kulkarni, Rohidas Arote and Rajendra H. Patil
RSC Advances 5 (41) 32376 (2015)
https://doi.org/10.1039/C5RA02669E

In Vivo Selection of Paromomycin and Miltefosine Resistance in Leishmania donovani and L. infantum in a Syrian Hamster Model

S. Hendrickx, A. Mondelaers, E. Eberhardt, et al.
Antimicrobial Agents and Chemotherapy 59 (8) 4714 (2015)
https://doi.org/10.1128/AAC.00707-15

Experimental selection of paromomycin and miltefosine resistance in intracellular amastigotes of Leishmania donovani and L. infantum

S. Hendrickx, G. Boulet, A. Mondelaers, et al.
Parasitology Research 113 (5) 1875 (2014)
https://doi.org/10.1007/s00436-014-3835-7

Elucidation of Cellular Mechanisms Involved in Experimental Paromomycin Resistance in Leishmania donovani

Vasundhra Bhandari, Shyam Sundar, Jean Claude Dujardin and Poonam Salotra
Antimicrobial Agents and Chemotherapy 58 (5) 2580 (2014)
https://doi.org/10.1128/AAC.01574-13

Fruitful Decade for Antileishmanial Compounds from 2002 to Late 2011

Hidayat Hussain, Ahmed Al-Harrasi, Ahmed Al-Rawahi, Ivan R. Green and Simon Gibbons
Chemical Reviews 114 (20) 10369 (2014)
https://doi.org/10.1021/cr400552x

Efficacy of low doses of amphotericin B plus allicin against experimental visceral leishmaniasis

M. J. Corral, D. R. Serrano, I. Moreno, et al.
Journal of Antimicrobial Chemotherapy 69 (12) 3268 (2014)
https://doi.org/10.1093/jac/dku290

Natural product based leads to fight against leishmaniasis

Nisha Singh, Bhuwan B. Mishra, Surabhi Bajpai, Rakesh K. Singh and Vinod K. Tiwari
Bioorganic & Medicinal Chemistry 22 (1) 18 (2014)
https://doi.org/10.1016/j.bmc.2013.11.048

Drug Resistance in Leishmaniasis: Current Drug-Delivery Systems and Future Perspectives

Masoom Yasinzai, Momin Khan, Akhtar Nadhman and Gul Shahnaz
Future Medicinal Chemistry 5 (15) 1877 (2013)
https://doi.org/10.4155/fmc.13.143

Experimental Induction of Paromomycin Resistance in Antimony-Resistant Strains of L. donovani: Outcome Dependent on In Vitro Selection Protocol

Sarah Hendrickx, Raquel Andrea Inocêncio da Luz, Vasundhra Bhandari, et al.
PLoS Neglected Tropical Diseases 6 (5) e1664 (2012)
https://doi.org/10.1371/journal.pntd.0001664

Leishmaniasis: Current status of available drugs and new potential drug targets

Nisha Singh, Manish Kumar and Rakesh Kumar Singh
Asian Pacific Journal of Tropical Medicine 5 (6) 485 (2012)
https://doi.org/10.1016/S1995-7645(12)60084-4

The stepwise selection for ketoconazole resistance induces upregulation of C14-demethylase (CYP51) in Leishmania amazonensis

Valter Viana Andrade-Neto, Herbert Leonel de Matos-Guedes, Daniel Cláudio de Oliveira Gomes, et al.
Memórias do Instituto Oswaldo Cruz 107 (3) 416 (2012)
https://doi.org/10.1590/S0074-02762012000300018

Therapeutic switching in leishmania chemotherapy: a distinct approach towards unsatisfied treatment needs

Nishi Shakya, Preeti Bajpai and Suman Gupta
Journal of Parasitic Diseases 35 (2) 104 (2011)
https://doi.org/10.1007/s12639-011-0040-9

Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial

Shyam Sundar, Prabhat Kumar Sinha, Madhukar Rai, et al.
The Lancet 377 (9764) 477 (2011)
https://doi.org/10.1016/S0140-6736(10)62050-8

In vitro and in vivo antileishmanial efficacy of a combination therapy of diminazene and artesunate against Leishmania donovani in BALB/c mice

Joshua Muli Mutiso, John Chege Macharia, Mustafa Barasa, et al.
Revista do Instituto de Medicina Tropical de São Paulo 53 (3) 129 (2011)
https://doi.org/10.1590/S0036-46652011000300003

Combination therapy for visceral leishmaniasis

Johan van Griensven, Manica Balasegaram, Filip Meheus, Jorge Alvar, Lutgarde Lynen and Marleen Boelaert
The Lancet Infectious Diseases 10 (3) 184 (2010)
https://doi.org/10.1016/S1473-3099(10)70011-6

Paromomycin: Uptake and resistance in Leishmania donovani

Anupam Jhingran, Bhavna Chawla, Shailendra Saxena, Michael Peter Barrett and Rentala Madhubala
Molecular and Biochemical Parasitology 164 (2) 111 (2009)
https://doi.org/10.1016/j.molbiopara.2008.12.007

Developments in the treatment of visceral leishmaniasis

Margriet Leontine den Boer, Jorge Alvar, Robert N Davidson, Koert Ritmeijer and Manica Balasegaram
Expert Opinion on Emerging Drugs 14 (3) 395 (2009)
https://doi.org/10.1517/14728210903153862

The Relationship between Leishmaniasis and AIDS: the Second 10 Years

Jorge Alvar, Pilar Aparicio, Abraham Aseffa, et al.
Clinical Microbiology Reviews 21 (2) 334 (2008)
https://doi.org/10.1128/CMR.00061-07

In vitro antileishmanial activity of acetogenins from Annonaceae

S. Raynaud-Le Grandic, C. Fourneau, A. Laurens, C. Bories, R. Hocquemiller and P.M. Loiseau
Biomedicine & Pharmacotherapy 58 (6-7) 388 (2004)
https://doi.org/10.1016/j.biopha.2004.02.007

Characterisation of atovaquone resistance in Leishmania infantum promastigotes

E Cauchetier, P.M Loiseau, J Lehman, et al.
International Journal for Parasitology 32 (8) 1043 (2002)
https://doi.org/10.1016/S0020-7519(02)00065-6